| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 359.56B | 342.55B | 283.08B | 241.88B | 184.39B | 155.75B |
| Gross Profit | 44.88B | 41.99B | 32.58B | 37.66B | 40.04B | 27.75B |
| EBITDA | 18.03B | 18.41B | 12.52B | 20.12B | 24.22B | 13.06B |
| Net Income | 9.97B | 8.86B | 6.74B | 11.85B | 14.75B | 7.62B |
Balance Sheet | ||||||
| Total Assets | 300.41B | 294.55B | 246.05B | 199.46B | 163.24B | 110.13B |
| Cash, Cash Equivalents and Short-Term Investments | 56.40B | 71.91B | 56.05B | 47.86B | 43.04B | 30.30B |
| Total Debt | 191.26B | 184.00B | 154.36B | 113.67B | 86.10B | 60.71B |
| Total Liabilities | 230.86B | 225.75B | 184.91B | 142.93B | 114.20B | 80.91B |
| Stockholders Equity | 61.22B | 60.14B | 54.51B | 50.99B | 44.04B | 24.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.04B | -16.09B | -17.01B | -21.51B | 11.52B |
| Operating Cash Flow | 0.00 | -626.00M | -15.28B | -16.39B | -20.71B | 12.01B |
| Investing Cash Flow | 0.00 | -7.54B | -4.89B | -2.48B | -3.11B | -348.92M |
| Financing Cash Flow | 0.00 | 22.21B | 27.07B | 22.39B | 36.56B | 4.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥98.91B | 14.61 | ― | 3.08% | -6.27% | -11.07% | |
74 Outperform | ¥115.52B | 5.88 | ― | 2.93% | 20.83% | 57.13% | |
73 Outperform | ¥134.83B | 20.19 | 15.81% | 2.93% | 84.20% | 137.87% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥54.93B | 9.84 | ― | 0.45% | -8.33% | -36.89% | |
62 Neutral | ¥75.82B | 8.53 | ― | 2.89% | -3.09% | -35.66% | |
58 Neutral | ¥212.86B | 9.79 | 20.50% | 1.49% | 2.50% | -71.61% |